Related references
Note: Only part of the references are listed.Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells
Giovanni Sette et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Patient-derived conditionally reprogrammed cells maintain intra-tumor genetic heterogeneity
Bruna R. S. Correa et al.
SCIENTIFIC REPORTS (2018)
Conditionally reprogrammed normal and primary tumor prostate epithelial cells: a novel patient-derived cell model for studies of human prostate cancer
Olga A. Timofeeva et al.
ONCOTARGET (2017)
Generation of stable PDX derived cell lines using conditional reprogramming
Alexandra Borodovsky et al.
MOLECULAR CANCER (2017)
Human primary liver cancer-derived organoid cultures for disease modeling and drug screening
Laura Broutier et al.
NATURE MEDICINE (2017)
Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens
Xuefeng Liu et al.
NATURE PROTOCOLS (2017)
Tracking the Evolution of Non-Small-Cell Lung Cancer
M. Jamal-Hanjani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Primary Patient-Derived Cancer Cells and Their Potential for Personalized Cancer Patient Care
David P. Kodack et al.
CELL REPORTS (2017)
Non-malignant epithelial cells preferentially proliferate from nasopharyngeal carcinoma biopsy cultured under conditionally reprogrammed conditions
Fenggang Yu et al.
SCIENTIFIC REPORTS (2017)
Rapid Expansion of Human Epithelial Stem Cells Suitable for Airway Tissue Engineering
Colin R. Butler et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
NOTCH1 and SOX10 are Essential for Proliferation and Radiation Resistance of Cancer Stem-Like Cells in Adenoid Cystic Carcinoma
Alex Panaccione et al.
CLINICAL CANCER RESEARCH (2016)
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Marc van de Wetering et al.
CELL (2015)
Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor
Zofia Piotrowska et al.
CANCER DISCOVERY (2015)
CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance
Kang-Seo Park et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Patient-derived models of acquired resistance can identify effective drug combinations for cancer
Adam S. Crystal et al.
SCIENCE (2014)
Tracking Genomic Cancer Evolution for Precision Medicine: The Lung TRACERx Study
Mariam Jamal-Hanjani et al.
PLOS BIOLOGY (2014)
Three-dimensional culture model to distinguish normal from malignant human bronchial epithelial cells
Delphine Fessart et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Kristian Cibulskis et al.
NATURE BIOTECHNOLOGY (2013)
A SNP profiling panel for sample tracking in whole-exome sequencing studies
Reuben J. Pengelly et al.
GENOME MEDICINE (2013)
ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells
Xuefeng Liu et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
Daniel C. Koboldt et al.
GENOME RESEARCH (2012)
Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor
Sandra Chapman et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
Share Paper
